Comprehensive clinical practice guidelines for managing hidradenitis suppurativa in special patient populations addressing the limited high-quality evidence and scarce guidance for excluded patient populations from clinical trials. These guidelines cover management approaches in pregnant, breastfeeding, pediatric, affected by malignancy, infected with tuberculosis, infected with hepatitis B or C, and diagnosed with human immunodeficiency virus, providing evidence-based recommendations and emphasizing the importance of multidisciplinary care.

Source: Journal of the American Academy of Dermatology